The U.S. health regulator has issued a warning letter to Jagsonpal Pharmaceuticals for significant manufacturing lapses at its Rajasthan-based active pharmaceutical ingredients (APIs) plant. The U.S. Food and Drug Administration (USFDA) identified deviations from Current Good Manufacturing Practice for APIs during inspections on multiple dates in 2024. The company must address the deficiencies within 15 working days to prevent further regulatory action and ensure compliance with CGMP requirements.
Full Article
Cristiano Ronaldo signs $700 million deal with Al Nassr
Cristiano Ronaldo has signed a groundbreaking $700 million contract with Saudi Arabian club Al Nassr, which includes extraordinary perks such as private jets, 16 personal staff, and a significant ownership stake in the club. This deal, touted as the largest in sports history, allows Ronaldo to retain more earnings due to Saudi Arabia's lack of income tax, setting a new precedent for athlete compensation. Explain It To Me Like I'm 5: Cristiano Ronaldo's groundbreaking $700...
Read more